<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01197131</url>
  </required_header>
  <id_info>
    <org_study_id>protocol 1.0/18/06/2010</org_study_id>
    <nct_id>NCT01197131</nct_id>
  </id_info>
  <brief_title>Urinary Steroid Metabolites in Autism</brief_title>
  <official_title>Investigation of Urinary Steroid Metabolites in Children With Autism Spectrum Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intersci Research Association, Austria</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Intersci Research Association, Austria</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Deviation of hormone formation within nerve cells and nerve system provides autism spectrum
      disorder and neurodevelopment retardation through interaction of steroids with
      neurotransmitter-receptors, calcium-channel receptors and genomic interaction via nuclear
      steroid receptors.

      Urinary steroid metabolites will be compared between children with autism spectrum disorder
      and healthy controls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Autism spectrum disorder presents many alterations in amino acid metabolism and in
      neurotransmitter systems (gamma amino acid system, glutamate-glutamine, nicotine-acid,
      serotonin-system) . Also alteration in gene activation within nerve cells and lymphocyte
      cultures encloses over 600 genes, affecting a wide field of enzymes , metabolic pathways and
      hormone formation. Male hormones and their precursors are often increased and their influence
      to nerve cell growth and spine formation is evident.

      The diagnosis of autism spectrum disorder is made in accordance of criteria of the Diagnostic
      and Statistical Manual of Mental Disorders IV (DSM-IV) of the American Psychiatric
      Association by an experienced and specialised paediatrician or psychologist and /or by an
      Autism Diagnostic Interview-Revised (ADI-R) or Autism Diagnostic Observation Schedule (ADOS)
      .

      Overnight urine with measurement of quantity and time will be collected and a little part of
      the urinary samples will be frozen for storage till analysis. Age, weight and length of the
      children at collection time will be ascertained.

      Four stratified groups (autistic boys, girls, and healthy controls, boys and girls, each age
      5-15) will be formed.

      Urinary samples will further remain anonymous through an Identification-Number (ID).

      Analysis of hormones and the most of the known metabolites excreted in urine will be
      performed by a specialised laboratory using gas chromatography-mass spectrometry (GC/MS)
      analysis (University Hospital Bern, Steroid Laboratory, Switzerland).

      The statistical analysis, with age, gender, weight, diagnosis and hormone analysis results as
      factors , consists in linear regression analysis to detect deviation in hormone formation and
      metabolism.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>difference in hormone formation and androgen precursors</measure>
    <time_frame>3 years</time_frame>
    <description>Calculation of hormone formation by comparison of urinary steroid metabolites</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>difference in hormone formation in gender and age</measure>
    <time_frame>3 years</time_frame>
    <description>Hormone formation depends on age and gender and will be calculated by comparison of urinary steroid metabolites</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">160</enrollment>
  <condition>Autism</condition>
  <condition>Autism Spectrum Disorder</condition>
  <arm_group>
    <arm_group_label>autistic boys</arm_group_label>
    <description>Boys with autism spectrum disorder, age 5-15 years, diagnosis meets DSM-IV criteria ascertained by ADI-R or ADOS schedule or specialised paediatrician</description>
  </arm_group>
  <arm_group>
    <arm_group_label>autistic girls</arm_group_label>
    <description>Girls with autism spectrum disorder, age 5-15 years, diagnosis meets DSM-IV criteria ascertained by ADI-R or ADOS schedule or specialised paediatrician.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control boys</arm_group_label>
    <description>Healthy boys, age 5-15 years, mental status assessed by &quot;Marburger Beurteilungsskala zum Asperger-Syndrome&quot; (MBAS).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control girls</arm_group_label>
    <description>Healthy girls, age 5-15 years, mental status assessed by &quot;Marburger Beurteilungsskala zum Asperger Syndrome&quot; (MBAS).</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      noninvasive overnight urine (morning urine)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Children , age 5-15 years with autism and autism spectrum disorder resident in Austria
        without other severe or psychiatric disorders.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Autism spectrum disorder

          -  Age 5-15 years

        Exclusion Criteria:

          -  Epilepsia

          -  Psychotropic medication

          -  other severe illness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johann Kurz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Intersci Research Association, Austria</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Intersci Research Association</name>
      <address>
        <city>Leibnitz</city>
        <state>Steiermark</state>
        <zip>8430</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <reference>
    <citation>Hu VW, Nguyen A, Kim KS, Steinberg ME, Sarachana T, Scully MA, Soldin SJ, Luu T, Lee NH. Gene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: altered pathways in neuronal development and steroid biosynthesis. PLoS One. 2009 Jun 3;4(6):e5775. doi: 10.1371/journal.pone.0005775.</citation>
    <PMID>19492049</PMID>
  </reference>
  <reference>
    <citation>Hu VW, Sarachana T, Kim KS, Nguyen A, Kulkarni S, Steinberg ME, Luu T, Lai Y, Lee NH. Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: evidence for circadian rhythm dysfunction in severe autism. Autism Res. 2009 Apr;2(2):78-97. doi: 10.1002/aur.73.</citation>
    <PMID>19418574</PMID>
  </reference>
  <reference>
    <citation>Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology. 2001 Nov 13;57(9):1618-28.</citation>
    <PMID>11706102</PMID>
  </reference>
  <reference>
    <citation>Geier DA, Geier MR. A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies. Neuro Endocrinol Lett. 2007 Oct;28(5):565-73.</citation>
    <PMID>17984958</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2010</study_first_submitted>
  <study_first_submitted_qc>September 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2010</study_first_posted>
  <last_update_submitted>May 10, 2018</last_update_submitted>
  <last_update_submitted_qc>May 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Intersci Research Association, Austria</investigator_affiliation>
    <investigator_full_name>Kurz Johann MD</investigator_full_name>
    <investigator_title>Medical Doctor,</investigator_title>
  </responsible_party>
  <keyword>autism</keyword>
  <keyword>autism spectrum disorder</keyword>
  <keyword>steroids</keyword>
  <keyword>steroid metabolites</keyword>
  <keyword>urinary steroid metabolites</keyword>
  <keyword>hormone formation</keyword>
  <keyword>androgen precursor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
    <mesh_term>Child Development Disorders, Pervasive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

